Envoy Medical (COCH) Cash from Financing Activities (2021 - 2026)

Envoy Medical has disclosed Cash from Financing Activities across 6 years of filings, most recently posting $27.6 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $27.6 million, up 675.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.7 million (up 134.64% YoY), and the FY2025 annual result was $16.6 million, down 17.65% from the prior year.
• Cash from Financing Activities came in at $27.6 million for Q1 2026 at Envoy Medical, up from $6.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $27.6 million in Q1 2026 to a low of -$1.5 million in Q4 2023.
• The 5-year median for Cash from Financing Activities is $4.0 million (2023), against an average of $5.5 million.
• Across the five-year window, Cash from Financing Activities surged 76633.33% in 2022 and sank 172.7% in 2023, its largest moves.
• Envoy Medical's Cash from Financing Activities stood at $2.0 million in 2022, then sank by 172.7% to -$1.5 million in 2023, then soared by 486.31% to $5.6 million in 2024, then gained by 7.53% to $6.0 million in 2025, then jumped by 356.52% to $27.6 million in 2026.
• The last three Cash from Financing Activities figures came in at $27.6 million (Q1 2026), $6.0 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.